Elekta AB (publ) (OTCMKTS:EKTAY) Stock Price Down 2.4% – Time to Sell?

Elekta AB (publ) (OTCMKTS:EKTAY)’s stock price fell 2.4% on Thursday . The stock traded as low as $5.67 and last traded at $5.68. 13,724 shares changed hands during trading, an increase of 49% from the average session volume of 9,188 shares. The stock had previously closed at $5.81.

Elekta AB (publ) Price Performance

The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.74 and a current ratio of 0.99. The company’s 50 day moving average price is $6.07 and its 200-day moving average price is $6.36. The company has a market cap of $2.21 billion, a price-to-earnings ratio of 23.00 and a beta of 1.23.

Elekta AB (publ) Company Profile

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.